In this article, we will take a look at the 5 most promising micro-cap stocks according to analysts. To see more such companies, go directly to 12 Most Promising Micro-Cap Stocks According to Analysts.
5. OptimizeRx Corporation (NASDAQ:OPRX)
Number of Hedge Fund Holders: 15
One-Year Average Price Target: $26.17
OptimizeRx Corporation (NASDAQ:OPRX) is a digital health technology company. OptimizeRx Corporation (NASDAQ:OPRX) ranks 5th in our list of the most promising micro-cap stocks according to analysts. In November, OptimizeRx Corporation (NASDAQ:OPRX) posted its third-quarter results. Adjusted EPS in the period came in at $0.07, beating estimates by $0.03. Revenue in the quarter fell 6.3% on a YoY basis to total of $15.1 million but still beat estimates by $0.08 million. OptimizeRx Corporation (NASDAQ:OPRX) said its gross profit in the quarter increased by 4% on a YoY basis. Cash, cash equivalents and short-term investments totaled $78.8 million as of the end of the third quarter of 2022.
Artisan Partners made the following comment about OptimizeRx Corporation (NASDAQ:OPRX) in its Q3 2022 investor letter:
“OptimizeRx Corporation (NASDAQ:OPRX) offers a platform of digital communications solutions between pharma companies and both prescribing physicians and patients. The company’s vast network of electronic health record partners/integrations enables pharma companies to more intelligently target and directly communicate to physicians about important clinical and financial information, leading to better prescribing decisions. Unfortunately, pharmaceutical companies have been dialing back their digital marketing spend given the waning macro backdrop, which has negatively impacted OptimizeRx’s profit cycle. Given our lack of visibility into when these headwinds will abate, we exited our position.”
4. Aadi Bioscience, Inc. (NASDAQ:AADI)
Number of Hedge Fund Holders: 15
One-Year Average Price Target: $42.50
As of mid-day trading on February 14, Aadi Bioscience, Inc. (NASDAQ:AADI) was trading at around $11.8, while its one-year price target is $42.50, which shows a huge upside from the current levels. Aadi Bioscience, Inc. (NASDAQ:AADI) develops therapies for genetically defined cancers with alterations in mTOR pathway genes.
A total of 15 hedge funds reported having stakes in Aadi Bioscience, Inc. (NASDAQ:AADI) as of the end of the third quarter of 2022.
3. Wheels Up Experience Inc. (NYSE:UP)
Number of Hedge Fund Holders: 17
One-Year Average Price Target: $3.54
Private aviation services company Wheels Up Experience Inc. (NYSE:UP) is a penny stock that has strong potential according to analysts. In December, Wheels Up Experience Inc. (NYSE:UP)’s shares rose after an SEC filing revealed that the company’s CEO bought 400,000 shares.
For the third quarter, Wheels Up Experience Inc. (NYSE:UP)’s EPS came in at -$0.36, beating estimates by $0.07. Revenue in the quarter jumped about 39.2% to a total of $420.36 million, surpassing estimates by $38.32 million. Active members in the period jumped 12% on a YoY basis to reach 12,688.
As of the end of the third quarter of 2022, 17 hedge funds reported owning shares in Wheels Up Experience Inc. (NYSE:UP). The total value of these stakes was over $8.3 million.
2. Atai Life Sciences N.V. (NASDAQ:ATAI)
Number of Hedge Fund Holders: 19
One-Year Average Price Target: $13.72
Clinical-stage biopharmaceutical company Atai Life Sciences N.V. (NASDAQ:ATAI) shares took a beating in January after the company said its majority-owned unit Perception Neuroscience’s therapy PCN-101 (R-ketamine) did not meet the main goal of a Phase 2a trial for treatment-resistant depression.
However, Atai Life Sciences N.V. (NASDAQ:ATAI)’s one-year average price target of $13.72 presents a solid upside from the current levels ($1.79 as of February 14 morning).
As of the end of the third quarter of 2022, 19 hedge funds tracked by Insider Monkey reported having stakes in Atai Life Sciences N.V. (NASDAQ:ATAI). The total value of these stakes was over $53 million. The biggest stakeholder of Atai Life Sciences N.V. (NASDAQ:ATAI) during this period was Catherine D. Wood’s ARK Investment Management which had a $20.3 million stake in the company.
1. Skillsoft Corp. (NYSE:SKIL)
Number of Hedge Fund Holders: 21
One-Year Average Price Target: $3.94
Skillsoft Corp. (NYSE:SKIL) is a digital learning services company with strong upside potential according to analysts as the workforce around the world flock to online learning platforms to upskill themselves to keep up with the changing industry trends. In December, Skillsoft Corp. (NYSE:SKIL) posted its third-quarter results. Revenue in the quarter came in at $139.39 million, beating estimates by $0.65 million. For fiscal 2023, Skillsoft Corp. (NYSE:SKIL) said it expects GAAP revenue to come between $520 million to $550 million, versus the consensus estimate of $571.70 million.
In January, Skillsoft Corp. (NYSE:SKIL) announced that it entered into a content partnership with Netherlands-based online skills training company GoodHabitz.
You can also take a peek at 10 Hot Tech Stocks To Buy Now and 10 Hot Healthcare Stocks To Buy Now.
